The LEADLESS Observational Study

CompletedOBSERVATIONAL
Enrollment

491

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2017

Study Completion Date

December 22, 2021

Conditions
Indications for VVI(R) Pacemaker
Interventions
DEVICE

Implanted with a Nanostim leadless pacemaker system

Trial Locations (32)

6080

Hospital Infanta Cristina, Badajoz

8025

Isala Klinieken, Zwolle

12200

Universitätsmedizin Berlin - Campus Benjamin Franklin, Berlin

13385

Hopital La Timone, Marseille

20014

Hospital Universitario Donostia, San Sebastián

20097

Policlinico San Donato, San Donato Milanese

20099

Asklepios Klinik St. Georg, Hamburg

20132

Ospedale San Raffaele, Milan

Ospedale Niguarda Ca'Granda, Milan

20138

Centro Cardiologico Monzino, Milan

24068

Azienda Ospedaliera Bolognini, Seriate

25124

Az. Osp. Spedali Civili di Brescia, Brescia

28046

Hospital Universitario de la Paz, Madrid

33604

Klinikum Bielefeld gGmbH Klinikum-Mitte, Bielefeld

35033

CHRU Hopital de Pontchaillou, Rennes

36214

Hospital do Meixoeiro, Vigo

37007

Hospital Universitario de Salamanca, Salamanca

38043

CHRU Albert Michallon, Grenoble

44270

Nouvelles cliniques Nantaises, Nantes

44625

Kath. Krankenhaus Marienhospital, Herne

61231

Kerckhoff-Klinik gGmbH, Bad Nauheim

67200

CHU Strasbourg - Hôpital de Hautepierre, Strasbourg

78052

Kliniken Villingen-Schwenningen, Villingen-Schwenningen

80636

Deutsches Herzzentrum München des Freistaates Bayern, München

150 30

Na Homolce Hospital, Prague

01307

Herzzentrum Dresden GmbH Universitätsklinik, Dresden

04289

Herzzentrum Leipzig GmbH, Leipzig

1105 AZ

AMC, Amsterdam

EC1A 7BE

St. Bartholomew's Hospital, London

SW3 6NP

Royal Brompton Hospital, London

M13 9WL

Manchester Heart Center, Manchester Royal Infirmary, Manchester

OX3 9DU

John Radcliffe Hospital, Oxford

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY